Detection Of Colon Cancer Research Articles

A Review on Lung and Colon Combine Cancer Detection using ML and DL Techniques

The detection of lung and colon cancer is a critical challenge in medical diagnosis, and machine learning (ML) and deep learning (DL) techniques are increasingly being used to enhance accuracy and efficiency. This review focuses on the integration of ML and DL methods for the combined detection of lung and colon cancer, emphasizing their strengths, limitations, and future potential. The motivation behind this study is to address the growing demand for accurate and early detection of these cancers, which significantly impacts treatment outcomes. Current methods often struggle with feature complexity, image variability, and computational intensity, which limit their real-world applicability. The aim is to consolidate various ML and DL techniques that have been employed for this purpose, highlighting how hybrid models can improve detection rates. The objective of this review is to provide a comprehensive analysis of different methodologies, their datasets, pre-processing techniques, feature extraction methods, and evaluation parameters. This review also explores recent advancements, such as transfer learning combined with fine-tuning techniques, which can further optimize performance in cancer detection. The findings suggest that while current methods show promise, further improvements in model generalization, interpretability, and computational efficiency are required to overcome existing limitations and expand clinical use.

Applying Deep-Learning Algorithm Interpreting Kidney, Ureter, and Bladder (KUB) X-Rays to Detect Colon Cancer.

Early screening is crucial in reducing the mortality of colorectal cancer (CRC). Current screening methods, including fecal occult blood tests (FOBT) and colonoscopy, are primarily limited by low patient compliance and the invasive nature of the procedures. Several advanced imaging techniques such as computed tomography (CT) and histological imaging have been integrated with artificial intelligence (AI) to enhance the detection of CRC. There are still limitations because of the challenges associated with image acquisition and the cost. Kidney, ureter, and bladder (KUB) radiograph which is inexpensive and widely used for abdominal assessments in emergency settings and shows potential for detecting CRC when enhanced using advanced techniques. This study aimed to develop a deep learning model (DLM) to detect CRC using KUB radiographs. This retrospective study was conducted using data from the Tri-Service General Hospital (TSGH) between January 2011 and December 2020, including patients with at least one KUB radiograph. Patients were divided into development (n = 28,055), tuning (n = 11,234), and internal validation (n = 16,875) sets. An additional 15,876 patients were collected from a community hospital as the external validation set. A 121-layer DenseNet convolutional network was trained to classify KUB images for CRC detection. The model performance was evaluated using receiver operating characteristic curves, with sensitivity, specificity, and area under the curve (AUC) as metrics. The AUC, sensitivity, and specificity of the DLM in the internal and external validation sets achieved 0.738, 61.3%, and 74.4%, as well as 0.656, 47.7%, and 72.9%, respectively. The model performed better for high-grade CRC, with AUCs of 0.744 and 0.674 in the internal and external sets, respectively. Stratified analysis showed superior performance in females aged 55-64 with high-grade cancers. AI-positive predictions were associated with a higher long-term risk of all-cause mortality in both validation cohorts. AI-enhanced KUB X-ray analysis can enhance CRC screening coverage and effectiveness, providing a cost-effective alternative to traditional methods. Further prospective studies are necessary to validate these findings and fully integrate this technology into clinical practice.

Preoperative Delta Neutrophil Index, Platelet Lymphocyte Ratio and Immature Granulocyte Count for Differentiating Metastatic Colon Cancer from Non-Metastatic Colon Cancer: A Retrospective Study.

Immature granulocytes show bone marrow activation before neutrophil response and there are studies in the literature showing that the number of immature granulocytes is an auxiliary marker in the diagnosis and treatment of different diseases. The Delta Neutrophil Index (DNI), Immature Granulocyte Count (IGC) have previously been studied as markers in thyroid and breast cancers. The aim of this study was to determine whether immature granulocyte IGC and DNI values measured in preoperative blood parameters have a diagnostic benefit for the detection of advanced colon cancer. A study was conducted on patients who had undergone selective operation for colon cancer in our clinic from February 2015 to February 2020. The patients were divided into two groups: early stage (stage I-III) and advanced stage (stage IV) colon cancer. The IGC and DNI values as well as other hematological parameters, demographic parameters (sex, age) in these two groups were compared. A total of 43 patients with mean age 67.47 (35-96) years were included in the study. Eighteen of the patients were male and 25 were female. When the early stage and advanced stage colon cancer groups were compared, no statistically significant difference was found between age, sex, white blood cell count, lymphocyte-to-monocyte ratio, eosinophil count, basophil count, mean platelet volume and: systemic immune-inflammation index score. It was observed that platelet-to-lymphocyte ratio, IGC and DNI or Immature Granulocyte Percentage (IGP) values were statistically significantly higher in the metastatic colon cancer group compared to the non-metastatic group. When the specificity and sensitivity of laboratory markers in metastatic colon cancer were examined, it was observed that the specificity and sensitivity of DNI or IGP and IGC were statistically higher than other values. DNI, IGC and PLR values, which are the parameters measured in the preoperative period are easily measurable laboratory parameters and do not involve additional costs in differentiating metastatic from non-metastatic colon cancer in the preoperative period.

Advanced Deep Learning Fusion Model for Early Multi-Classification of Lung and Colon Cancer Using Histopathological Images.

In recent years, the healthcare field has experienced significant advancements. New diagnostic techniques, treatments, and insights into the causes of various diseases have emerged. Despite these progressions, cancer remains a major concern. It is a widespread illness affecting individuals of all ages and leads to one out of every six deaths. Lung and colon cancer alone account for nearly two million fatalities. Though it is rare for lung and colon cancers to co-occur, the spread of cancer cells between these two areas-known as metastasis-is notably high. Early detection of cancer greatly increases survival rates. Currently, histopathological image (HI) diagnosis and appropriate treatment are key methods for reducing cancer mortality and enhancing survival rates. Digital image processing (DIP) and deep learning (DL) algorithms can be employed to analyze the HIs of five different types of lung and colon tissues. Therefore, this paper proposes a refined DL model that integrates feature fusion for the multi-classification of lung and colon cancers. The proposed model incorporates three DL architectures: ResNet-101V2, NASNetMobile, and EfficientNet-B0. Each model has limitations concerning variations in the shape and texture of input images. To address this, the proposed model utilizes a concatenate layer to merge the pre-trained individual feature vectors from ResNet-101V2, NASNetMobile, and EfficientNet-B0 into a single feature vector, which is then fine-tuned. As a result, the proposed DL model achieves high success in multi-classification by leveraging the strengths of all three models to enhance overall accuracy. This model aims to assist pathologists in the early detection of lung and colon cancer with reduced effort, time, and cost. The proposed DL model was evaluated using the LC25000 dataset, which contains colon and lung HIs. The dataset was pre-processed using resizing and normalization techniques. The model was tested and compared with recent DL models, achieving impressive results: 99.8% for precision, 99.8% for recall, 99.8% for F1-score, 99.96% for specificity, and 99.94% for accuracy. Thus, the proposed DL model demonstrates exceptional performance across all classification categories.

Augmented histopathology: Enhancing colon cancer detection through deep learning and ensemble techniques.

Colon cancer poses a significant threat to human life with a high global mortality rate. Early and accurate detection is crucial for improving treatment quality and the survival rate. This paper presents a comprehensive approach to enhance colon cancer detection and classification. The histopathological images are gathered from the CRC-VAL-HE-7K dataset. The images undergo preprocessing to improve quality, followed by augmentation to increase dataset size and enhance model generalization. A deep learning based transformer model is designed for efficient feature extraction and enhancing classification by incorporating a convolutional neural network (CNN). A cross-transformation model captures long-range dependencies between regions, and an attention mechanism assigns weights to highlight crucial features. To boost classification accuracy, a Siamese network distinguishes colon cancer tissue classes based on probabilities. Optimization algorithms fine-tune model parameters, categorizing colon cancer tissues into different classes. The multi-class classification performance is evaluated in the experimental evaluation, which demonstrates that the proposed model provided highest accuracy rate of 98.84%. In this research article, the proposed method achieved better performance in all analyses by comparing with other existing methods. RESEARCH HIGHLIGHTS: Deep learning-based techniques are proposed. DL methods are used to enhance colon cancer detection and classification. CRC-VAL-HE-7K dataset is utilized to enhance image quality. Hybrid particle swarm optimization (PSO) and dwarf mongoose optimization (DMO) are used. The deep learning models are tuned by implementing the PSO-DMO algorithm.

Awareness of Colorectal Cancer Preventive Measures Among Residents of Riyadh.

Background Colorectal cancer (CRC) poses a significant challenge to healthcare providers. Spreading awareness, providing preventive measures, and implementing screening programs are essential for detecting and halting the progression of the disease and decreasing the mortality associated with this type of malignancy. This study aimed to assess public knowledge and awareness of colorectal cancer preventive measures and screening programs among residents of Riyadh, Saudi Arabia, and also to design better healthcare interventions or policy development. Methods This cross-sectional study was carried out among residents in Riyadh, Saudi Arabia. A self-administered questionnaire was sent to participants using a Google survey. The questionnaire consisted of socio-demographic characteristics (age, gender, marital status, and occupation), a general understanding of CRC and its prevention, risk factors for developing CRC, barriers to undergoing CRC screening, and a 21-item questionnaire to assess awareness of CRC preventive measures. Results Of the 420 respondents, 301 (71.7%) were female, and 134 (31.9%) were between 18 and 29 years old. The overall mean awareness score was 12.5 (SD 3.05) out of 21 points. Accordingly, 240 (57.1%) were categorized as having moderate awareness, 70 (16.7%) as good, and 110 (26.2%) had poor awareness levels. Being younger, being unmarried, having heard of CRC and screening tests that detect colon cancer, and being aware of the CRC early detection campaign in Saudi Arabia were the factors associated with increased awareness. Conclusion There was modest awareness of CRC preventive measures among residents living in Riyadh. Significant predictors of increased awareness include younger age, being unmarried, having heard of CRC, having heard of screening tests to detect CRC, and awareness of the CRC early-detection campaigns in Saudi Arabia. Healthcare providers have a vital role in increasing awareness of CRC's preventive measures.

Exploiting histopathological imaging for early detection of lung and colon cancer via ensemble deep learning model

Cancer seems to have a vast number of deaths due to its heterogeneity, aggressiveness, and significant propensity for metastasis. The predominant categories of cancer that may affect males and females and occur worldwide are colon and lung cancer. A precise and on-time analysis of this cancer can increase the survival rate and improve the appropriate treatment characteristics. An efficient and effective method for the speedy and accurate recognition of tumours in the colon and lung areas is provided as an alternative to cancer recognition methods. Earlier diagnosis of the disease on the front drastically reduces the chance of death. Machine learning (ML) and deep learning (DL) approaches can accelerate this cancer diagnosis, facilitating researcher workers to study a vast majority of patients in a limited period and at a low cost. This research presents Histopathological Imaging for the Early Detection of Lung and Colon Cancer via Ensemble DL (HIELCC-EDL) model. The HIELCC-EDL technique utilizes histopathological images to identify lung and colon cancer (LCC). To achieve this, the HIELCC-EDL technique uses the Wiener filtering (WF) method for noise elimination. In addition, the HIELCC-EDL model uses the channel attention Residual Network (CA-ResNet50) model for learning complex feature patterns. Moreover, the hyperparameter selection of the CA-ResNet50 model is performed using the tuna swarm optimization (TSO) technique. Finally, the detection of LCC is achieved by using the ensemble of three classifiers such as extreme learning machine (ELM), competitive neural networks (CNNs), and long short-term memory (LSTM). To illustrate the promising performance of the HIELCC-EDL model, a complete set of experimentations was performed on a benchmark dataset. The experimental validation of the HIELCC-EDL model portrayed a superior accuracy value of 99.60% over recent approaches.

Detection of Lung and Colon Cancer from Histopathological Images: Using Convolutional Networks and Transfer Learning

Detection of Lung and Colon Cancer from Histopathological Images: Using Convolutional Networks and Transfer Learning

Colon cancer diagnosis by means of explainable deep learning

Early detection of the adenocarcinoma cancer in colon tissue by means of explainable deep learning, by classifying histological images and providing visual explainability on model prediction. Considering that in recent years, deep learning techniques have emerged as powerful techniques in medical image analysis, offering unprecedented accuracy and efficiency, in this paper we propose a method to automatically detect the presence of cancerous cells in colon tissue images. Various deep learning architectures are considered, with the aim of considering the best one in terms of quantitative and qualitative results. As a matter of fact, we consider qualitative results by taking into account the so-called prediction explainability, by providing a way to highlight on the tissue images the areas that from the model point of view are related to the presence of colon cancer. The experimental analysis, performed on 10,000 colon issue images, showed the effectiveness of the proposed method by obtaining an accuracy equal to 0.99. The experimental analysis shows that the proposed method can be successfully exploited for colon cancer detection and localisation from tissue images.

Colon Cancer Disease Diagnosis Based on Convolutional Neural Network and Fishier Mantis Optimizer.

Colon cancer is a prevalent and potentially fatal disease that demands early and accurate diagnosis for effective treatment. Traditional diagnostic approaches for colon cancer often face limitations in accuracy and efficiency, leading to challenges in early detection and treatment. In response to these challenges, this paper introduces an innovative method that leverages artificial intelligence, specifically convolutional neural network (CNN) and Fishier Mantis Optimizer, for the automated detection of colon cancer. The utilization of deep learning techniques, specifically CNN, enables the extraction of intricate features from medical imaging data, providing a robust and efficient diagnostic model. Additionally, the Fishier Mantis Optimizer, a bio-inspired optimization algorithm inspired by the hunting behavior of the mantis shrimp, is employed to fine-tune the parameters of the CNN, enhancing its convergence speed and performance. This hybrid approach aims to address the limitations of traditional diagnostic methods by leveraging the strengths of both deep learning and nature-inspired optimization to enhance the accuracy and effectiveness of colon cancer diagnosis. The proposed method was evaluated on a comprehensive dataset comprising colon cancer images, and the results demonstrate its superiority over traditional diagnostic approaches. The CNN-Fishier Mantis Optimizer model exhibited high sensitivity, specificity, and overall accuracy in distinguishing between cancer and non-cancer colon tissues. The integration of bio-inspired optimization algorithms with deep learning techniques not only contributes to the advancement of computer-aided diagnostic tools for colon cancer but also holds promise for enhancing the early detection and diagnosis of this disease, thereby facilitating timely intervention and improved patient prognosis. Various CNN designs, such as GoogLeNet and ResNet-50, were employed to capture features associated with colon diseases. However, inaccuracies were introduced in both feature extraction and data classification due to the abundance of features. To address this issue, feature reduction techniques were implemented using Fishier Mantis Optimizer algorithms, outperforming alternative methods such as Genetic Algorithms and simulated annealing. Encouraging results were obtained in the evaluation of diverse metrics, including sensitivity, specificity, accuracy, and F1-Score, which were found to be 94.87%, 96.19%, 97.65%, and 96.76%, respectively.

Non-invasive colorectal cancer detection using multimodal deep learning ensemble classifier.

3066 Background: The demand for alternative, non-invasive methods for colorectal cancer (CRC) screening is substantial. Cell-free DNA (cfDNA) whole genome sequencing (WGS) offers a promising avenue, utilizing diverse fragmentomic data. We aimed to develop a new approach: integrating fragment end motif by size (FEMS) with genomic coverage (COV) of cfDNA to enhance CRC screening. Methods: Participants were comprised of 1,506 colonoscopy verified normal samples, 130 advanced adenoma (AA) patients, 302 CRC patients (stage I: 28.5%, stage II: 25.5%, stage III: 31.1%, stage IV: 14.2%, unknown: 0.7%). We generated low depth cfDNA-WGS data (a minimum 40 million reads per sample) using the Novaseq 6000 sequencer. We minimized batch bias by normalizing with the same samples for each experimental batch. The development set comprised 1,332 samples (1,023 normal, 103 AA, and 206 CRC), while the validation set consisted of 606 samples (483 normal, 27 AA, and 96 CRC). Results: Our new algorithm achieved 84.0% sensitivity (95% CI: 81%-86%) for CRC and 69.9% (95% CI: 66%-81%) for AA in the development set, with a specificity of 90.0%. These findings were consistent in the external set with 84.9% specificity (95% CI: 82%-88%) and sensitivities of 80.2% (95% CI: 72%-88%) and 63.0% (95% CI: 44%-82%) for CRC and AA, respectively. The sensitivities across stages (Stage I: 80%, Stage II: 86.8%, Stage III: 78.8%, Stage IV: 96.7%) were similarly reflected in the validation sets (Stage I: 74%, Stage II: 83%, Stage III: 79%, Stage IV: 92%). Conclusions: Our multimodal deep learning model shows promise for accurate non-invasive colon cancer and AA detection using low-coverage cfDNA WGS. Its strong performance in detecting not only CRC but also AA lesions suggests its potential for early intervention and improved patient outcomes. The use of colonoscopy-verified normal samples strengthens the study's credibility and paves the way for future clinical translation.

Colon Cancer Detection of Colonoscopy Images Using CNN

Abstract: Colon cancer requires an early and precise diagnosis in order to be effectively treated because it is a common and potentially fatal condition. This study proposes a reliable framework for colon cancer detection through image preprocessing and transfer learning approaches. The research compares the performance of three popular convolutional neural networks (CNNs) for this task: VGG-15, ResNet-50, and AlexNet.The image preprocessing phase entails a number of critical operations, including image conversion, resizing, and contrast enhancement using histogram equalization. In order to guarantee that the neural networks receive high-quality inputs, these preprocessing techniques strive to improve the quality and consistency of the colon cancer dataset. Pre-trained models extract and classify features from big datasets using transfer learning. The preprocessed colon cancer dataset is used to fine-tune the chosen CNN architectures VGG-15, ResNet-50, and AlexNet and adapt them for this particular medical imaging purpose.The results of this study show that transfer learning has the potential for colon cancer detection and provides helpful direction for researchers and practitioners looking for the best deep-learning architectures for early cancer diagnosis. This study adds to continuing efforts to improve the precision and effectiveness of colon cancer detection techniques, ultimately leading to better patient outcomes.

A novel hybrid model for lung and colon cancer detection using pre-trained deep learning and KELM

Cancer poses a significant threat to life due to its aggressive nature, high potential for metastasis, and heterogeneity. Globally, both the men and women are mostly affected by lung and colon (LC) cancer. Early and accurate detection is essential to enhance the well-being of patients facing LC cancer. The traditional techniques face challenges such as low accuracy and high execution time. This work combines the pre-trained deep learning (DL) models like ResNet-50, InceptionV3, and DenseNet with Kernel Extreme Learning Machine (KELM) for the accurate and fast diagnosis of LC cancer using histopathology images. The pre-trained DL models provide a strong foundation for feature extraction, capturing intricate patterns indicative of cancerous tissues. Feature fusion combines the complementary strengths of multiple pre-trained models, enhancing the method's ability to capture diverse features and improve classification accuracy. KELM efficiently handles the high-dimensional feature space generated by the DL models, ensuring fast and accurate classification. Mutation Boosted Dwarf Mongoose Optimization Algorithm (MB-DMOA) further optimizes the model parameters, mitigating the risk of getting stuck in local optima and facilitating better convergence towards the global optimum. By leveraging the advantages of each technique and integrating them into a cohesive framework, the proposed approach achieves superior performance in diagnosing LC cancer, ultimately improving patient outcomes. The proposed study attains accuracy (98.9%), F1-score (97.6%), specificity (96.5%), precision (96.7%) and sensitivity (95.8%). The results illuminate the efficacy of this approach within therapeutic environments.

Lung and Colon Cancer Histopathological Image Classification Using 1D Convolutional Channel-based Attention Networks

Lung and Colon cancer are the leading diseases of death and disability in humans caused by a combination of genetic diseases and biochemical abnormalities. If these are diagnosed in their early stages, they can not be spread in organs and negatively impact human life. Many deep-learning networks have recently been proposed to detect and classify these malignancies. However, incorrect detection or misclassification of these fatal diseases can significantly affect an individual's health and well-being. This paper introduces a novel, cost-effective, and mobile-embedded architecture to diagnose and classify Lung squamous cell carcinomas and adenocarcinomas of the lung and colon from digital pathology images. Extensive experiment shows that our proposed modifications achieve 100% testing results for lung, colon, and lung-and-colon cancer detection. Our novel architecture takes around 0.65 million trainable parameters and around 6.4 million flops to achieve the best lung and colon cancer detection performance. Compared with the other results, our proposed architecture shows state-of-the-art performance.

A Machine Learning Approach for Detection and Classification of Colon Cancer using Convolutional Neural Network Architecture

In both developing and developed countries, cancer has become one of the most fearsome health ailments in the 21st century. Among the different variants of cancer, colon cancer is the 3rd most prevalent cancer globally and the 2nd deadliest form of cancer. Early diagnosis is very critical for the successful treatment of colon cancer. In recent times, machine-learning approaches have made significant strides in IoT-assisted healthcare systems. Computer-aided diagnostic systems driven by deep learning algorithms can detect colon cancer with great accuracy, assisting the medical profession in quick diagnosis and developing quick remedies against it. In our approach, we have developed a deep learning model based on convolutional neural network architecture to accurately classify and detect colon cancer. The developed model has been trained with 10,000 histopathological images of the colon, divided into two classes: colon adenocarcinoma and colon benign tissues, each containing 5000 images. We have also employed various performance metrics in our research to monitor the performance of our machine-learning model. The proposed model has been trained for 30 epochs with a batch size of 32 and achieved an overall accuracy of 98.79%.

A Novel Optimized Colonic adenocarcinoma Detection using Deep Transfer Learning Approach with XceptionTS Model

Colonic adenocarcinoma is a major contributor to global mortality, highlighting the crucial need for efficient detection and classification techniques. This research presents a new method called XceptionTS for classifying and detecting colon cancer using colonoscopy pictures. The XceptionTS method utilizes deep transfer learning techniques by leveraging the Xception model architecture. Nonlinear Mean Filtering (NMF) is used as a noise reduction method in image processing to improve the quality of colonoscopy pictures. We combine the MobileNetV2 and ResNet-50 models for healthcare image segmentation and feature extraction, respectively. The XceptionTS classifier efficiently gives accurate class labels to medical photos by combining Tabu Search Optimization with the strong Xception architecture. The assessment of the effectiveness of XceptionTS model is done using a dataset of 1560 colonoscopy images. An extensive comparison study is undertaken by analyzing the efficacy of our suggested approach with existing research. The XceptionTS system outperforms previous methodologies in colon cancer classification and detection tasks, showing higher accuracy and robustness according to experimental results. Our findings indicate that the XceptionTS technique shows potential as an advanced tool to increase the effectiveness of Colonic adenocarcinoma diagnosis, which could lead to better patient outcomes and healthcare management.

Elevated cardiovascular risk and acute events in hospitalized colon cancer survivors: A decade-apart study of two nationwide cohorts.

Over the years, strides in colon cancer detection and treatment have boosted survival rates; yet, post-colon cancer survival entails cardiovascular disease (CVD) risks. Research on CVD risks and acute cardiovascular events in colorectal cancer survivors has been limited. To compare the CVD risk and adverse cardiovascular outcomes in current colon cancer survivors compared to a decade ago. We analyzed 2007 and 2017 hospitalization data from the National Inpatient Sample, studying two colon cancer survivor groups for CVD risk factors, mortality rates, and major adverse events like pulmonary embolism, arrhythmia, cardiac arrest, and stroke, adjusting for confounders via multivariable regression analysis. Of total colon cancer survivors hospitalized in 2007 (n = 177542) and 2017 (n = 178325), the 2017 cohort often consisted of younger (76 vs 77 years), male, African-American, and Hispanic patients admitted non-electively vs the 2007 cohort. Furthermore, the 2017 cohort had higher rates of smoking, alcohol abuse, drug abuse, coagulopathy, liver disease, weight loss, and renal failure. Patients in the 2017 cohort also had higher rates of cardiovascular comorbidities, including hypertension, hyperlipidemia, diabetes, obesity, peripheral vascular disease, congestive heart failure, and at least one traditional CVD (P < 0.001) vs the 2007 cohort. On adjusted multivariable analysis, the 2017 cohort had a significantly higher risk of pulmonary embolism (PE) (OR: 1.47, 95%CI: 1.37-1.48), arrhythmia (OR: 1.41, 95%CI: 1.38-1.43), atrial fibrillation/flutter (OR: 1.61, 95%CI: 1.58-1.64), cardiac arrest including ventricular tachyarrhythmia (OR: 1.63, 95%CI: 1.46-1.82), and stroke (OR: 1.28, 95%CI: 1.22-1.34) with comparable all-cause mortality and fewer routine discharges (48.4% vs 55.0%) (P < 0.001) vs the 2007 cohort. Colon cancer survivors hospitalized 10 years apart in the United States showed an increased CVD risk with an increased risk of acute cardiovascular events (stroke 28%, PE 47%, arrhythmia 41%, and cardiac arrest 63%). It is vital to regularly screen colon cancer survivors with concomitant CVD risk factors to curtail long-term cardiovascular complications.

An End-to-End Lightweight Multi-Scale CNN for the Classification of Lung and Colon Cancer with XAI Integration

To effectively treat lung and colon cancer and save lives, early and accurate identification is essential. Conventional diagnosis takes a long time and requires the manual expertise of radiologists. The rising number of new cancer cases makes it challenging to process massive volumes of data quickly. Different machine learning approaches to the classification and detection of lung and colon cancer have been proposed by multiple research studies. However, when it comes to self-learning classification and detection tasks, deep learning (DL) excels. This paper suggests a novel DL convolutional neural network (CNN) model for detecting lung and colon cancer. The proposed model is lightweight and multi-scale since it uses only 1.1 million parameters, making it appropriate for real-time applications as it provides an end-to-end solution. By incorporating features extracted at multiple scales, the model can effectively capture both local and global patterns within the input data. The explainability tools such as gradient-weighted class activation mapping and Shapley additive explanation can identify potential problems by highlighting the specific input data areas that have an impact on the model’s choice. The experimental findings demonstrate that for lung and colon cancer detection, the proposed model was outperformed by the competition and accuracy rates of 99.20% have been achieved for multi-class (containing five classes) predictions.

As how artificial intelligence is revolutionizing endoscopy.

With incessant advances in information technology and its implications in all domains of our lives, artificial intelligence (AI) has emerged as a requirement for improved machine performance. This brings forth the query of how this can benefit endoscopists and improve both diagnostic and therapeutic endoscopy in each part of the gastrointestinal tract. Additionally, it also raises the question of the recent benefits and clinical usefulness of this new technology in daily endoscopic practice. There are two main categories of AI systems: computer-assisted detection (CADe) for lesion detection and computer-assisted diagnosis (CADx) for optical biopsy and lesion characterization. Quality assurance is the next step in the complete monitoring of high-quality colonoscopies. In all cases, computer-aided endoscopy is used, as the overall results rely on the physician. Video capsule endoscopy is a unique example in which a computer operates a device, stores multiple images, and performs an accurate diagnosis. While there are many expectations, we need to standardize and assess various software packages. It is important for healthcare providers to support this new development and make its use an obligation in daily clinical practice. In summary, AI represents a breakthrough in digestive endoscopy. Screening for gastric and colonic cancer detection should be improved, particularly outside expert centers. Prospective and multicenter trials are mandatory before introducing new software into clinical practice.

Automatic lung and colon cancer detection using enhanced cascade convolution neural network

Automatic lung and colon cancer detection using enhanced cascade convolution neural network